SCHEMBL22029370

SCHEMBL22029370

CC(C)(C)OC(=O)CCCCCCCCCCCCCc1ccc(Oc2ccc(S(=O)(=O)Nc3cnc(C(=O)O)nc3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP1 Q9NUW8 3/20 0.41
▸ HDAC1 Q13547 3/20 0.41
▸ POLB P06746 1/20 0.41
▸ GFER P55789 1/20 0.40
▸ HDAC8 Q9BY41 2/20 0.39
▸ PSEN1 P49768 1/20 0.39
▸ PSEN2 P49810 1/20 0.39
▸ APH1B Q8WW43 1/20 0.39
▸ NCSTN Q92542 1/20 0.39
▸ APH1A Q96BI3 1/20 0.39
▸ PSENEN Q9NZ42 1/20 0.39
▸ ADRB3 P13945 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ TBXA2R P21731 1/20 0.38
▸ TBXAS1 P24557 1/20 0.38
▸ CACNA1B Q00975 2/20 0.37
▸ GHSR Q92847 1/20 0.37
▸ FABP1 P07148 1/20 0.37
▸ FFAR1 O14842 1/20 0.37
▸ FFAR4 Q5NUL3 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31682053 0.95 HDAC1 (0.44) TDP1HDAC1POLBHDAC8PSEN1
SCHEMBL31682055 0.95 HDAC1 (0.44) TDP1HDAC1POLBHDAC8PSEN1
SCHEMBL31682111 0.93 POLB (0.50) TDP1HDAC1POLBHDAC8PSEN1
SCHEMBL31681968 0.93 POLB (0.50) TDP1HDAC1POLBHDAC8PSEN1
SCHEMBL31682026 0.93 HDAC1 (0.43) TDP1HDAC1POLBHDAC8PSEN1
SCHEMBL31682042 0.91 HDAC1 (0.46) TDP1HDAC1POLBHDAC8PSEN1
SCHEMBL22029351 0.89 TDP1 (0.41) TDP1HDAC1POLBHDAC8ADRB3
SCHEMBL31682076 0.88 PSEN1 (0.40) TDP1HDAC1GFERHDAC8PSEN1
SCHEMBL31682126 0.88 PSEN1 (0.40) TDP1HDAC1GFERHDAC8PSEN1
SCHEMBL22029393 0.88 HDAC1 (0.50) TDP1HDAC1HDAC8PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3893934-B1 INSULIN CONJUGATES SANOFI SA (FR) 2025-09-10 — — EP disclosed
US-12195510-B2 Insulin conjugates SANOFI (FR) 2025-01-14 — — US disclosed
US-20220048968-A1 INSULIN CONJUGATES SANOFI (FR) 2022-02-17 — — US disclosed
US-20200181223-A1 INSULIN CONJUGATES SANOFI (FR) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200181223-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R TDP1 4783/4885HDAC1 2572/4885POLB 4107/4885
US-20220048968-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R TDP1 4783/4885HDAC1 2572/4885POLB 4107/4885
US-12195510-B2 Insulin conjugates IAPP, INSR, IGF1R TDP1 4783/4885HDAC1 2572/4885POLB 4107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback